在阿尔茨海默氏症的疾病中,铁性,热性和性
Qi Wang1, Jingyi Sun2, Tian Chen3
1College of Integrated Chinese and Western Medicine, Changchun University of Chinese Medicine, Changchun 130117, Jilin, China.
ACS chemical neuroscience
|September 13, 2023
概括
阿尔茨海默病 (AD) 涉及神经退行. 本综述探讨了细胞死亡类型 (如铁亡,热亡和亡) 如何导致阿尔茨海默病,并确定了潜在的治疗点.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 老年学是指老年学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是老年人痴呆的主要原因,其特征是渐进性的认知能力下降.
- 调节性细胞死亡对于维持平衡至关重要,并且越来越多地与阿尔茨海默病的发病有关.
- 铁亡,热亡和亡是与AD发病,进展和结果相关的受调细胞死亡的特定形式.
研究的目的:
- 检讨基础上的分子机制铁,热和cuproptosis.
- 阐明这些细胞死亡途径在阿尔茨海默病中的调节作用.
- 根据这些机制,确定AD治疗的潜在治疗点.
主要方法:
- 关于分子机制的文献综述.
- 对阿尔茨海默病发病过程中的调节作用的分析.
- 治疗目标的探索.
主要成果:
- 铁,热和杯与阿尔茨海默病有显著的关联.
- 了解这些途径为AD发展和预后提供了洞察力.
- 这些细胞死亡过程中的特定分子标正在出现.
结论:
- 铁,热和杯是阿尔茨海默病的关键参与者.
- 针对这些受调节的细胞死亡途径为AD治疗提供了一个有希望的途径.
- 对这些机制的进一步研究可能会彻底改变AD治疗策略.
关键词:
阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.这就是cuproptosis.铁性化 (ferroptosis) 是一种这是一个机制机制.热致灭 (pyroptosis) 是一种致的过程.调节细胞死亡 (RCD)更多相关视频
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
1.0K
12:48In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
Published on: May 11, 2015
10.6K
相关概念视频
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
